Integrated genomic characterization of oesophageal carcinoma

Abstract

Oesophageal cancers are prominent worldwide; however, there are few targeted therapies and survival rates for these cancers remain dismal. Here we performed a comprehensive molecular analysis of 164 carcinomas of the oesophagus derived from Western and Eastern populations. Beyond known histopathological and epidemiologic distinctions, molecular features differentiated oesophageal squamous cell carcinomas from oesophageal adenocarcinomas. Oesophageal squamous cell carcinomas resembled squamous carcinomas of other organs more than they did oesophageal adenocarcinomas. Our analyses identified three molecular subclasses of oesophageal squamous cell carcinomas, but none showed evidence for an aetiological role of human papillomavirus. Squamous cell carcinomas showed frequent genomic amplifications of CCND1 and SOX2 and/or TP63, whereas ERBB2, VEGFA and GATA4 and GATA6 were more commonly amplified in adenocarcinomas. Oesophageal adenocarcinomas strongly resembled the chromosomally unstable variant of gastric adenocarcinoma, suggesting that these cancers could be considered a single disease entity. However, some molecular features, including DNA hypermethylation, occurred disproportionally in oesophageal adenocarcinomas. These data provide a framework to facilitate more rational categorization of these tumours and a foundation for new therapies.

References 57

1. 1.

   De Angelis R, et al. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE—5-a population-based study. Lancet Oncol. 15;23-34.

   Not in our library10.1016/s1470-2045(13)70546-1

2. 2.

   Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7-30.

   Not in our library10.3322/caac.21332

3. 3.

   Torre LA, et al. Global cancer statistics, 2012. CA Cancer J Clin. 65;87-108.

   Not in our library10.3322/caac.21262

4. 4.

   Siewert JR, Ott K. Are squamous and adenocarcinomas of the esophagus the same disease? Semin Radiat Oncol. 2007;17:38-44.

   Not in our library10.1016/j.semradonc.2006.09.007

5. 5.

   Brown LM, Devesa SS, Chow WH. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst. 2008;100:1184-1187.

   Not in our library10.1093/jnci/djn211

6. 6.

   Devesa SS, Fraumeni JF. The rising incidence of gastric cardia cancer. J Natl Cancer Inst. 1999;91:747-749.

   Not in our library10.1093/jnci/91.9.747

7. 7.

   Rice TW, Blackstone EH, Rusch VW. 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction. Ann Surg Oncol. 2010;17:1721-1724.

   Not in our library10.1245/s10434-010-1024-1

8. 8.

   Suh YS, et al. Should adenocarcinoma of the esophagogastric junction be classified as esophageal cancer? A comparative analysis according to the seventh AJCC TNM classification. Ann Surg. 2012;255:908-915.

   Not in our library10.1097/sla.0b013e31824beb95

9. 9.

   Leers JM, et al. Clinical characteristics, biologic behavior, and survival after esophagectomy are similar for adenocarcinoma of the gastroesophageal junction and the distal esophagus. J Thorac Cardiovasc Surg. 2009;138:594-602.

   Not in our library10.1016/j.jtcvs.2009.05.039

10. 10.

    Shen R, Olshen AB, Ladanyi M. Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysis. Bioinformatics. 2009;25:2906-2912.

    Not in our library10.1093/bioinformatics/btp543

11. 11.

    Carneiro P, et al. E-cadherin dysfunction in gastric cancer—cellular consequences, clinical applications and open questions. FEBS Lett. 2012;586:2981-2989.

    Not in our library10.1016/j.febslet.2012.07.045

12. 12.

    Barbieri CE, Tang LJ, Brown KA, Pietenpol JA. Loss of p63 leads to increased cell migration and up-regulation of genes involved in invasion and metastasis. Cancer Res. 2006;66:7589-7597.

    Not in our library10.1158/0008-5472.can-06-2020

13. 13.

    Lawrence MS, et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 2013;499:214-218.

    Not in our library10.1038/nature12213

14. 14.

    Cheng C, et al. Whole-genome sequencing reveals diverse models of structural variations in esophageal squamous cell carcinoma. Am J Hum Genet. 2016;98:256-274.

    Not in our library10.1016/j.ajhg.2015.12.013

15. 15.

    Gao YB, et al. Genetic landscape of esophageal squamous cell carcinoma. Nat Genet. 2014;46:1097-1102.

    Not in our library10.1038/ng.3076

16. 16.

    Lin DC, et al. Genomic and molecular characterization of esophageal squamous cell carcinoma. Nat Genet. 2014;46:467-473.

    Not in our library10.1038/ng.2935

17. 17.

    Qin HD, et al. Genomic characterization of esophageal squamous cell carcinoma reveals critical genes underlying tumorigenesis and poor prognosis. Am J Hum Genet. 2016;98:709-727.

    Not in our library10.1016/j.ajhg.2016.02.021

18. 18.

    Sawada G, et al. Genomic landscape of esophageal squamous cell carcinoma in a Japanese population. Gastroenterology. 2016;150:1171-1182.

    Not in our library10.1053/j.gastro.2016.01.035

19. 19.

    Song Y, et al. Identification of genomic alterations in oesophageal squamous cell cancer. Nature. 2014;509:91-95.

    Not in our library10.1038/nature13176

20. 20.

    Zhang L, et al. Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma. Am J Hum Genet. 2015;96:597-611.

    Not in our library10.1016/j.ajhg.2015.02.017

21. 21.

    Dulak AM, et al. Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nat Genet. 2013;45:478-486.

    Not in our library10.1038/ng.2591

22. 22.
    GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers · 2011

    No notice
23. 23.

    Bandla S, et al. Comparative genomics of esophageal adenocarcinoma and squamous cell carcinoma. Ann Thorac Surg. 2012;93:1101-1106.

    Not in our library10.1016/j.athoracsur.2012.01.064

24. 24.

    Bang YJ, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010;376:687-697.

    Not in our library10.1016/s0140-6736(10)61121-x

25. 25.

    Bass AJ, et al. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet. 2009;41:1238-1242.

    Not in our library10.1038/ng.465

26. 26.

    Dulak AM, et al. Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis. Cancer Res. 2012;72:4383-4393.

    Not in our library10.1158/0008-5472.can-11-3893

27. 27.

    Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513:202-209.

    Not in our library10.1038/nature13480

28. 28.

    Lin L, et al. Activation of GATA binding protein 6 (GATA6) sustains oncogenic lineage-survival in esophageal adenocarcinoma. Proc Natl Acad Sci USA. 2012;109:4251-4256.

    Not in our library10.1073/pnas.1011989109

29. 29.

    Shibata T, et al. NRF2 mutation confers malignant potential and resistance to chemoradiation therapy in advanced esophageal squamous cancer. Neoplasia. 2011;13:864-873.

    Not in our library10.1593/neo.11750

30. 30.

    Komatsu M, et al. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat Cell Biol. 2010;12:213-223.

    Not in our library10.1038/ncb2021

31. 31.

    Taguchi K, et al. Keap1 degradation by autophagy for the maintenance of redox homeostasis. Proc Natl Acad Sci USA. 2012;109:13561-13566.

    Not in our library10.1073/pnas.1121572109

32. 32.

    Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012;489:519-525.

    Not in our library10.1038/nature11404

33. 33.

    Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015;517:576-582.

    Not in our library10.1038/nature14129

34. 34.

    Twiddy D, Cohen GM, Macfarlane M, Cain K. Caspase-7 is directly activated by the approximately 700-kDa apoptosome complex and is released as a stable XIAP-caspase-7 approximately 200-kDa complex. J Biol Chem. 2006;281:3876-3888.

    Not in our library10.1074/jbc.m507393200

35. 35.

    Li SX, et al. Tetherin/BST-2 promotes dendritic cell activation and function during acute retrovirus infection. Sci Rep. 2016;6:20425.

    Not in our library10.1038/srep20425

36. 36.

    Cui R, et al. Functional variants in ADH1B and ALDH2 coupled with alcohol and smoking synergistically enhance esophageal cancer risk. Gastroenterology. 2009;137:1768-1775.

    Not in our library10.1053/j.gastro.2009.07.070

37. 37.

    Alexandrov LB, et al. Signatures of mutational processes in human cancer. Nature. 2013;500:415-421.

    Not in our library10.1038/nature12477

38. 38.

    Petrick JL, et al. Prevalence of human papillomavirus among oesophageal squamous cell carcinoma cases: systematic review and meta-analysis. Br J Cancer. 2014;110:2369-2377.

    Not in our library10.1038/bjc.2014.96

39. 39.

    Hasina R, et al. O-6-methylguanine-deoxyribonucleic acid methyltransferase methylation enhances response to temozolomide treatment in esophageal cancer. J Carcinog. 2013;12:20.

    Not in our library10.4103/1477-3163.120632

40. 40.

    Yun T, et al. Methylation of CHFR sensitizes esophageal squamous cell cancer to docetaxel and paclitaxel. Genes Cancer. 2015;6:38-48.

    Not in our library10.18632/genesandcancer.46

Cited by papers we hold 45

• HER2-targeted therapies in cancer: a systematic review · 2024
  No notice
• Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial · 2024
  No notice
• Notch1 mutations drive clonal expansion in normal esophageal epithelium but impair tumor growth · 2023
  No notice
• Extrachromosomal DNA in the cancerous transformation of Barrett’s oesophagus · 2023
  No notice
• Clinical validation of a 90-gene expression test for tumor tissue of origin diagnosis: a large-scale multicenter study of 1417 patients · 2022
  Not checked
• Integrative Genomic Analyses of 1,145 Patient Samples Reveal New Biomarkers in Esophageal Squamous Cell Carcinoma · 2022
  Not checked
• N7-methylguanosine tRNA modification promotes esophageal squamous cell carcinoma tumorigenesis via the RPTOR/ULK1/autophagy axis · 2022
  No notice
• Multi-Region Genomic Landscape Analysis for the Preoperative Prediction of Lymph Node Metastasis in Esophageal Carcinoma · 2022
  Not checked
• Establish immune-related gene prognostic index for esophageal cancer · 2022
  Not checked
• Stratification From Heterogeneity of the Cell-Death Signal Enables Prognosis Prediction and Immune Microenvironment Characterization in Esophageal Squamous Cell Carcinoma · 2022
  Not checked
• Drugging KRAS: current perspectives and state-of-art review · 2022
  No notice
• Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer · 2022
  No notice
• An ensemble of the iCluster method to analyze longitudinal lncRNA expression data for psoriasis patients · 2021
  Not checked
• Dissecting esophageal squamous-cell carcinoma ecosystem by single-cell transcriptomic analysis · 2021
  No notice
• A multi‐omics study delineates new molecular features and therapeutic targets for esophageal squamous cell carcinoma · 2021
  Not checked
• Advances in Drug Resistance of Esophageal Cancer: From the Perspective of Tumor Microenvironment · 2021
  Not checked
• Evaluating the transcriptional fidelity of cancer models · 2021
  Not checked
• Molecular targets in GI malignancies – A pathologist's perspective · 2021
  Not checked
• Autophagic Heterogeneity in Gastric Adenocarcinoma · 2021
  Not checked
• Occurrence of High Microsatellite-Instability/Mismatch Repair Deficiency in Nearly 2,000 Human Adenocarcinomas of the Gastrointestinal Tract, Pancreas, and Bile Ducts: A Study From a Large German Comprehensive Cancer Center · 2021
  Not checked

and 25 more

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.